Engflag

Haem-UP

Quick links to important sections

Haem-UP

Haem-UP_L

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Haem-UP

What is Haem-UP? Defining the Haematinic Agent

Property Description
Active ingredient Iron, B Vitamins, Trace Elements, Glycerinated Haemoglobin
Form Oral Solution (Therapeutic Tonic)
Pharmacological class Haematinic Agent, Nutritional Supplement
Common use Supporting blood formation and mineral balance
Origin Compound Preparation (Mineral Salts, Vitamins, Protein Derivative)

Haem-UP is defined as an Oral Solution classified as a Haematinic Nutritional Supplement, intended to support and maintain key metabolic functions related to blood renewal. This Compound Preparation is administered systemically via the oral route, a characteristic often preferred for certain patient groups over solid forms. The formulation's primary classification as a Haematinic Agent stems from its role in supplying essential materials required for haemopoiesis, the fundamental process of blood cell formation.

Composition: Essential Elements and Trace Minerals

This preparation is a multi-ingredient formulation, combining several active components crucial for systemic support. Its core ingredients include the readily utilized Iron source Ferric Ammonium Citrate, along with the B-complex vitamins Cyanocobalamin (Vitamin B12) and Folic Acid (Vitamin B9). A distinguishing feature is the inclusion of the protein derivative Glycerinated Haemoglobin, which supports the iron components, alongside the Trace Elements Zinc Sulphate, Manganese Sulphate, and Cupric Sulphate. Ferric Ammonium Citrate, as an Iron compound, is recognized for its function as a Nutrient Supplement. These active constituents are delivered in an aqueous base that incorporates Alcohol to ensure the necessary stability and preservation of the liquid formulation.

General Purpose: Why is Haem-UP Used?

The general purpose of this supplement is to contribute to the proper functioning of the body's machinery for creating and maintaining healthy blood, specifically by sustaining erythropoiesis. Both Folic Acid and Cyanocobalamin have a crucial role in cellular proliferation and DNA synthesis, which are prerequisites for red blood cell production. By supplying this combination of vital vitamins and Trace Elements, including Iron, the preparation is fundamentally intended to support the entire systemic process of blood renewal in individuals requiring nutritional supplementation.

What side effects are possible with Haem-UP?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety constraints for Haem-UP, based on governmental regulatory sources. The profile is categorized by frequency and the body system affected.

Adverse Reaction Classification

Classification Examples of Documented Reactions
Common Nausea, Vomiting, Constipation, Diarrhea, Abdominal pain, Dark-colored stools.
Uncommon Headache, Dizziness, Allergic skin reactions (rash, itching), Taste changes, Injection-site reactions (for parenteral forms).
Rare/Very Rare Severe allergic reactions (Anaphylaxis), Hypotension, Collapse (for injectable forms).

Clinically Significant Adverse Reactions

Serious adverse events explicitly listed in regulatory documents include severe hypersensitivity reactions, which may manifest as difficulty breathing or swelling of the face, lips, tongue, or throat. These require immediate medical attention.

Safety-Related Restrictions and Contraindications

Haem-UP is formally contraindicated (must not be used) in patients with specific conditions, including:

  • Known hypersensitivity to the drug or its components.
  • Anemia that is not caused by iron deficiency.
  • Conditions involving iron overload, such as Hemochromatosis or Hemosiderosis.

Caution is advised and use should be monitored in specific populations, including patients with liver or kidney impairment, and when administering to children due to the high risk of iron overdose toxicity. The oral form should generally not be used concurrently with the injectable form.

Overdose and Emergency Response

The section on Haem-UP Overdose and when to seek help explains the officially documented manifestations and required emergency response actions for iron-containing haematinic agents.

Overdose typically presents with severe gastrointestinal symptoms, including persistent vomiting, abdominal pain, and potential bloody vomiting. These initial signs can quickly progress to systemic toxicity, manifesting as lethargy, seizures, or rapid heart rate, potentially leading to life-threatening complications like shock, low blood pressure, severe metabolic acidosis, and liver failure.

Regulators mandate that individuals must seek emergency medical attention immediately for any suspected overdose. Contacting emergency services or a Poison Control Center is required at once, particularly if symptoms escalate to collapse, unresponsiveness, or breathing difficulty.

Official regulatory warnings specify that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Management in a healthcare setting includes continuous monitoring, supportive care, and specific procedural interventions, such as chelation therapy, used to treat severe, systemic iron toxicity.

Therapeutic Uses of Haem-UP

Targeting Fatigue and Weakness from Nutritional Anaemia

This preparation is primarily used to address nutritional deficiency anaemia resulting from inadequate intake or absorption of essential blood-forming nutrients, including Iron, Folic Acid, and Vitamin B12. This lack of nutrients can lead to symptoms associated with reduced oxygen delivery, causing the core symptom cluster of pervasive fatigue, persistent weakness, and general lethargy, which are symptoms related to systemic imbalance. The haematinic is commonly used to help relieve these symptoms by providing supportive relief when symptoms interfere with routine activities.

Supporting Periods of High Physiological Demand

Haem-UP is applied in clinical scenarios where the physiological need for blood-forming nutrients is significantly elevated, or where chronic deficiencies are common. It is relevant when supportive symptom management is appropriate for conditions involving nutritional deficiency anaemia, chronic blood loss, and increased demands during pregnancy or lactation. The supplement assists with maintaining functional stability and is often used to assist patients managing chronic low-level blood loss or nutritional malabsorption.

Quick Fact: Relief for Iron-Deficiency Fatigue

Addressing Cognitive and Physical Manifestations

Beyond fatigue, this agent assists with managing associated chronic manifestations of deficiency. It may assist with improving cognitive function (such as concentration and mental clarity) and may assist with addressing physical signs such as unusual paleness and reduced appetite, which are secondary consequences of the underlying deficit. This supportive relief helps patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus overview on Anemia

Eligibility and Restrictions for Use

Who can and cannot use Haem-UP? — Official Regulatory Information

Official regulatory documentation for this combination haematinic agent defines eligibility based on iron status, deficiency type, and specific health conditions.

Eligibility Status Defined Population Groups
Use is Contraindicated Individuals with Iron Overload disorders, such as hemochromatosis or hemosiderosis (due to the iron content).
Use is Contraindicated Patients with known hypersensitivity to Iron, Folic Acid, Cyanocobalamin, or any other ingredient.
Use is Restricted Patients with undiagnosed megaloblastic anaemia; Folic Acid may mask the progression of neurological damage from Vitamin B12 deficiency.
Use is Restricted Those with severe hepatic (liver) or renal (kidney) impairment, requiring caution and monitoring.
Not Established in Young children, with many formulations being designated for adults or adolescents over 12 years only.

Use is generally permitted for adults with documented nutritional deficiency anaemia involving iron and B vitamins. In pregnancy and lactation, use is common for deficiency management but is advised under medical guidance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents emphasize that the primary interactions associated with iron-containing products like Haem-UP involve reduced absorption of either the iron supplement or other co-administered medications.

Documented Interacting Categories and Products

The following categories and specific products have documented interactions, often necessitating a separation in dosing timing:

Category/Product Interaction Implication Practical Constraint
Antibiotics (Tetracyclines, Quinolones) Reduced absorption and efficacy of the antibiotic. Separate administration by at least 2–4 hours.
Bisphosphonates, Thyroid Hormones, Levodopa Reduced absorption and efficacy of these medicines. Separate administration by at least 2–4 hours.
Antacids, Calcium/Zinc Supplements Reduced absorption and efficacy of the iron supplement. Avoid taking within 2 hours of iron.

Food and Substance Restrictions

Consumption of certain foods and beverages can significantly interfere with the absorption of iron. It is officially advised to avoid concurrent intake of products such as milk and dairy products, tea, coffee, and cocoa, as they contain substances like phytates and tannins that inhibit iron absorption. Alcohol consumption is also generally advised against due to the potential to exacerbate effects.

Interaction Mechanism and Constraints

The mechanism for these interactions is typically chelation or binding, where the iron element forms complexes with the other drug or substance in the gastrointestinal tract, making neither product fully available for absorption. The resulting regulatory constraint is the mandatory timing separation between Haem-UP and many prescription and over-the-counter medicines to prevent a clinically significant loss of therapeutic effect.

Mechanism of Action

Iron and Heme Synthesis Regulation

Haem-UP provides ferrous iron, which acts as the core substrate for the molecular cascade that synthesizes the heme component of hemoglobin within developing red blood cells. This mechanism facilitates the iron incorporation step into the porphyrin ring. The resulting physiological consequence is the increased substrate availability necessary for the production of functional hemoglobin within the hematopoietic system.

Red Blood Cell Maturation and DNA Replication

This formulation includes folic acid (Vitamin B9) and cyanocobalamin (Vitamin B12), which function as essential cofactors in the synthesis of DNA and are crucial for the division and maturation of precursor cells. This pathway modulation is necessary for the cell division sequence of erythrocytes in the bone marrow. The influence supports the necessary cellular progression and differentiation required for sustained erythropoiesis.

Trace Mineral-Mediated Iron Metabolism

Haem-UP introduces trace elements, including copper and manganese, which engage in enzymatic processes supporting iron utilization efficiency. Copper is required for the oxidation and mobilization of iron from its storage sites and for its subsequent incorporation into the synthesizing erythroid cells. This engagement influences the systemic flow of iron, contributing to its metabolic availability.

Dosage and Administration Information

How to Use Haem-UP: Administration Guidelines

The administration of Haem-UP (Iron Sucrose Injection) is strictly managed by a healthcare professional and is not a self-administered treatment. The instructions below summarize the procedural requirements, focusing on how the medicine must be used.

Administration Procedure

Procedural Element Requirement
Route of Administration Must be given as a slow injection directly into a vein (intravenous, IV).
Personnel Administration must be performed by a doctor or nurse (qualified healthcare professional).
Dosage and Frequency The dose and the schedule (e.g., how often it is given) are individually determined by the treating physician based on the patient's body weight and the required amount of iron.
Preparation The solution must be visually inspected before use; only clear solutions without particles may be used for injection.

Required Monitoring

Following the injection, specific management steps are required to ensure procedural adherence and patient safety:

  • Post-Injection Observation: The patient must be observed for a defined period (e.g., at least 30 minutes) after each administration is completed.
  • Blood Monitoring: The treating physician must regularly monitor the patient's blood parameters, including blood cell counts and iron levels, throughout the course of treatment.

The required steps establish that the use of Haem-UP is strictly managed by a medical team. The individualized dosing, mandatory professional administration, and required blood monitoring all structure the protocol for correctly receiving the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Haem-UP

The research evidence for Haem-UP, a haematinic agent, focuses on the clinical evaluation of its core active ingredients (Iron, B Vitamins, and Trace Elements) used in the context of specific nutritional deficiencies. The studies described here are primarily drawn from official governmental and peer-reviewed scientific sources.

Evidence for Nutritional Deficiency Anaemia

Research exploring the use of these components in people with nutritional deficiency anaemia has utilized Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that combine data from many different studies. Studies monitored changes in key blood markers, such as haemoglobin ( Hb) concentration and serum ferritin, reporting measured patterns over short-term periods, typically lasting 4 to 12 weeks, in observed populations presenting as deficient. Some trials also reported how symptoms such as fatigue evolved in the observed populations, with findings describing patterns where symptoms related to physical discomfort changed during the study period.

However, the findings reported across different trials varied because researchers used different types of iron compounds and dosing schedules, which can make direct comparisons difficult. Furthermore, there is limited information for long-term outcomes and the durability of the effect after supplementation is stopped.

Research on Anaemia During Pregnancy

The research base for using these components during pregnancy is extensive, relying on numerous Randomized Controlled Trials and comprehensive Cochrane Reviews. These studies monitored pregnant women to assess the use of the ingredients both for preventing and addressing anaemia. Findings described patterns where studies measured the incidence of maternal anaemia and metrics concerning birth weight in populations receiving supplementation. Observations were consistently reported across studies spanning the entire pregnancy through to the immediate postpartum period.

The evidence contributes to understanding deficiency correction during pregnancy, but data are still emerging regarding the long-term impact on the infant beyond the initial birth measures. Additionally, the results apply only to the populations studied, and adherence to the study protocol was a factor that researchers noted as a potential influence on findings.

What Remains Uncertain About Haematinic Evidence

Several areas of uncertainty exist within the evidence base. Long-term effects are not fully established, and there is limited information for the effects of supplementation over many years. Comparative evidence is lacking to definitively understand how this specific multi-ingredient preparation compares to individual, high-dose iron salts in certain contexts. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Anemia - NIH MedlinePlus Overview
  2. Oral Iron Supplementation for Anemia in Adults (PubMed Meta-analysis)

Frequently Asked Questions (FAQ)

Common questions about Haem-UP (FAQ)

Q: How is Haem-UP commonly described in relation to other iron supplements?

A: Official documents classify Haem-UP as a multi-ingredient haematinic agent. This means it is a preparation that combines an iron source with B-complex vitamins and trace elements. This approach differs from that of many common supplements, which contain only a single iron salt.

Q: Is Haem-UP considered a vitamin supplement or a medicinal product?

A: According to official sources, Haem-UP Oral Solution is classified as a Haematinic Nutritional Supplement. Its purpose is to support blood formation and general mineral balance by supplying essential nutrients.

Q: Is it normal for stool color to change while taking Haem-UP?

A: Yes, regulatory documents list dark-colored stools as a common adverse reaction associated with iron-containing products. This change is commonly recognized during the course of treatment.

Q: Does Haem-UP cause skin rashes?

A: Regulatory documents list allergic skin reactions, such as rash or itching, in the uncommon category of adverse reactions. Serious adverse events, such as severe hypersensitivity reactions, are required to be managed by a medical team.

Q: Is there a connection between taking Haem-UP and headaches?

A: Headaches are listed in the product's regulatory documents as an uncommon adverse reaction. While not frequently reported, this effect is recognized in the safety information.

Q: Is it advisable to consume alcohol while using Haem-UP?

A: Official regulatory advice recommends avoiding alcohol consumption while using the product. This recommendation is due to the potential for alcohol to exacerbate certain effects of the supplement.

Q: What general categories of medicines are known to interact with Haem-UP?

A: The official product information lists documented interactions with several categories of medicines. These include certain antibiotics (like tetracyclines and quinolones), bisphosphonates, thyroid hormones, and antacids or calcium/zinc supplements. Timing separation is a common regulatory constraint often advised to prevent reduced absorption.

Q: How long is a typical course of treatment with Haem-UP?

A: The duration of treatment is determined by the required individual iron repletion. Treatment is typically continued until the body’s iron stores are assessed as fully replenished, which can take several weeks or months.

Q: Does Haem-UP require a prescription in most locations?

A: Haem-UP is officially classified as a Haematinic Nutritional Supplement. Like many iron supplements, it is typically sold over-the-counter, but regulatory safety guidelines require it to carry warnings about the risk of accidental iron overdose, especially in children.

Q: Can Haem-UP be used by people with diabetes?

A: The standard oral solution contains alcohol and may incorporate sweetening agents. Sugar-free alternative formulations are commercially available to address the needs of patients who require strict monitoring of their blood sugar levels.

Q: Is Haem-UP appropriate for people who follow a vegetarian or vegan diet?

A: The composition of Haem-UP includes Glycerinated Haemoglobin. Heme components and haemoglobin are sourced from animal origins. Individuals following a strict vegetarian or vegan diet may review the ingredients for alignment with their dietary constraints.

Q: Does Haem-UP boost energy levels in people who are not iron deficient?

A: Research evidence focuses on the product’s role in supporting blood formation when nutritional deficiency is present. Studies monitored changes in physical discomfort and fatigue in these populations.

Q: Can Haem-UP help with issues like hair loss or brittle nails?

A: Official documents classify the product for its use in nutritional deficiency anaemia. Hair loss and brittle nails are sometimes related to nutritional status, but the product’s function is defined by its role in supplying essential elements for blood renewal as specified in the official regulatory information.

Q: Why is Haem-UP often recommended for people with chronic blood loss?

A: The product is generally recommended because chronic blood loss is a documented medical cause that frequently leads to nutritional deficiency anaemia. The supplement is intended to address this primary condition by supplying essential elements for blood renewal.

Q: What blood parameters are monitored during treatment with Haem-UP?

A: Regulatory studies and clinical monitoring protocols typically monitor key blood parameters to assess changes in iron status during treatment. These commonly include haemoglobin ( Hb) concentration and serum ferritin levels.

Q: How long does it usually take to notice the effects or improvements from Haem-UP?

A: Research trials monitoring changes in blood markers and symptoms in observed populations typically report measured patterns over short-term periods. These monitoring periods generally span 4 to 12 weeks.

Q: What is the standard guidance if a dose of Haem-UP is missed?

A: The general guidance for this type of supplement is to take the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped.

Q: Is Haem-UP generally suitable for elderly patients (over 65)?

A: The product is not listed as formally contraindicated in elderly populations in regulatory documents. However, official information states that use in all patient groups requires monitoring, and the appropriate dose is individually determined.

Q: Does Haem-UP have an impact on blood sugar levels since it is available as a syrup?

A: The standard oral solution formulation is an aqueous base that typically incorporates sweetening agents. Sugar-free alternative formulations are commercially available to address the needs of patients who require strict monitoring of their blood sugar levels.

Q: What is the difference between Haem-UP and common over-the-counter iron supplements?

A: Haem-UP is a multi-ingredient preparation combining an Iron source (Ferric Ammonium Citrate), B-complex vitamins, and Trace Elements. In contrast, many common over-the-counter iron supplements contain only a single iron salt.

Q: Does Haem-UP contain elemental iron, and if so, is the amount standardized?

A: The active iron source is Ferric Ammonium Citrate. Official drug regulations require that the specific amount of elemental iron available in the product be standardized and defined on the product labeling.

Q: Is it generally recommended to take Haem-UP with food or on an empty stomach?

A: Studies indicate that iron absorption is typically greater when the supplement is taken on an empty stomach. However, official guidance often recommends taking it with food to reduce the potential for gastrointestinal side effects like nausea or stomach upset.

Q: Are there any age restrictions for taking Haem-UP?

A: The regulatory documentation indicates that use is not established in young children. Many formulations are designated only for adults or adolescents over 12 years of age.

How should Haem-UP be stored and disposed of?

How to Store and Dispose of Haem-UP

The storage and disposal of Haem-UP Oral Solution must adhere strictly to official regulatory guidelines to maintain its stability and ensure safety.

Official Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, typically below 30°C and do not freeze the liquid.
Protection Keep the product in its original, tightly closed container and protect it from light and excessive moisture.
Child Safety Due to the iron content, it is mandatory to store the solution out of the sight and reach of children to prevent accidental poisoning.

Disposal Instructions

Expired or unused Haem-UP must not be thrown in household trash or poured down a drain. Dispose of the product through an official medicine take-back program or in accordance with local pharmaceutical waste requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Haem-UP found in:

A-Z Index: